Diaceutics(GB:DXRX)
GBX 194.00-1.00 (-0.51%)
GB:DXRX
Diaceutics financials statements
GBX 194.00
At close:-1.00 (-0.51%)
Want to see GB:DXRX full AI Analyst Report?
Diaceutics (DXRX) Income Statement
13 Followers
Diaceutics Income Statement
Last quarter (Q2 2026), Diaceutics's total revenue was £17.46M, an increase of 41.69% from the same quarter last year. In Q2, Diaceutics's net income was £-2.77M. See Diaceutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 38.44M | £ 32.16M | £ 23.70M | £ 19.50M | £ 13.94M | |
| £ 26.12M | £ 28.27M | £ 19.71M | £ 14.04M | £ 10.57M | |
| £ 25.88M | £ 30.73M | £ 22.72M | £ 13.71M | £ 10.25M | |
| Depreciation and Amortization | £ 5.81M | £ 4.63M | £ 4.77M | £ 3.01M | £ 1.80M |
| £ 6.08M | £ 2.77M | £ 2.36M | £ 3.61M | £ 2.35M | |
| £ 266.00K | £ -2.46M | £ -3.02M | £ 575.00K | £ 550.00K | |
| £ -26.00K | £ 547.00K | £ 580.00K | £ -11.00K | £ -88.00K | |
| £ 240.00K | £ -1.91M | £ -2.44M | £ 564.00K | £ 462.00K | |
| £ 97.00K | £ -1.70M | £ -1.75M | £ 724.00K | £ 561.00K | |
| Per Share Metrics | |||||
| Basic EPS | £ 0.00 | £ -0.02 | £ -0.02 | £ 0.01 | £ 0.01 |
| Diluted EPS | £ 0.00 | £ -0.02 | £ -0.02 | £ 0.01 | £ 0.01 |
| Weighted Average Shares Outstanding | 84.58M | 84.45M | 84.23M | 84.15M | 83.94M |
| Weighted Average Shares Outstanding (Diluted) | 85.13M | 84.45M | 84.23M | 86.09M | 84.94M |
Currency in GBP
